Diseases, Conditions, Syndromes

Immunity after COVID-19 illness may last at least 1 year

Long-term data from northern Italy—an area hit hard during the early days of the pandemic—suggests that reinfection after recovery from COVID-19 infection is very rare, and immunity in former patients could be long-lasting.

Oncology & Cancer

Researchers engineer cells to better target cancer

In cell-based immunotherapy, a treatment being explored for cancer, the body's immune cells are modified to eliminate cancer cells more effectively. Immune cells can kill cancer cells on their own but have some difficulty ...

Diseases, Conditions, Syndromes

Could SARS-CoV-2 evolve resistance to COVID-19 vaccines?

Similar to bacteria evolving resistance to antibiotics, viruses can evolve resistance to vaccines, and the evolution of SARS-CoV-2 could undermine the effectiveness of vaccines that are currently under development, according ...

page 6 from 29